Form Type: 4

SEC EDGAR Link
Accession Number:0001192482-21-000555
Date:2021-06-14
Issuer: RECRO PHARMA, INC. (REPH)
Original Submission Date:

Reporting Person:

PARKS LAURA L.
C/O RECRO PHARMA, INC.
1 E. UWCHLAN AVE, SUITE 112 EXTON, PA 19341

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 2.23 2021-06-14 deemed execution date A 20,000 (a) 2031-06-14 common stock 20,000 $2.23 20,000 direct
Footnotes
IDfootnote
f1 the option will vest in three equal annual installments, beginning on june 14, 2022, subject to the reporting person's continuous service with the company.

Elevate your investments